Clinical Trial

AI for Onsite Cytology Evaluation in Endoscopic Ultrasound

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The aim of this study is to determine if the widely available artificial intelligence platform ChatGPT can accurately identify the abnormalities present on cytology specimens obtained at EUS-FNB of solid mass lesions in the gastrointestinal tract, in comparison with interpretation by cytopathologists as the gold standard.
Protocol Amendment History 1 change
critical Primary endpoint(s) modified 2026-07-01
Trial Details
NCT Number NCT07228689
Lead Sponsor Orlando Health, Inc.
Conditions Gastrointestinal Neoplasm, Mass Lesion
Enrollment 136 participants
Start Date 2025-11-17
Primary Completion 2026-04-06 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2026-06-30